Skip to content

CollPlant Biotechnologies Ltd

CLGN · XNAS

CIK 1631487fmd_0VVPNDV3QC2R16D76EBZPYEQDVManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 01, 2015 to Dec 31, 2025, 20 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues0526160–12
Cost of revenue022320221
Gross profit030314(0)9(1)2
Research and development444481010118
Selling, general and administrative244––––––
Total operating expenses–230–––––
Operating income(6)(4)(8)(6)0(17)(8)(17)(11)
Interest expense023––––––
Interest and investment income––––00110
Other non-operating income (expense)––(4)(0)0001(0)
Income tax expense––––––6046–
Net income(6)(6)(11)(6)0(17)(7)(17)(11)
CollPlant Biotechnologies Ltd (CLGN) financial statements · FinancialMD